Genscript Biotech Corp (1548)

Currency in HKD
16.95
-0.26(-1.51%)
Closed·
1548 Scorecard
Full Analysis
Net income is expected to grow this year
1548 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.7617.29
52 wk Range
8.8818.96
Key Statistics
Bid/Ask
16.94 / 16.96
Prev. Close
17.21
Open
17
Day's Range
16.76-17.29
52 wk Range
8.88-18.96
Volume
21.07M
Average Volume (3m)
28.99M
1-Year Change
31.57%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1548 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
21.61
Upside
+27.48%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Genscript Biotech Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Genscript Biotech Corp Company Profile

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. The Life Science Services and Products segment provides products and services in various categories, including gene synthesis, oligonucleotide synthesis, peptide synthesis, protein engineering, antibody development, and life-science equipment and consumables, such as molecular diagnostics tools and genome editing materials for biology studies, pharmaceutical and drug discovery, disease diagnostics and vaccine, agriculture, environmental studies, and the food industry. The Biologics Development Services segment which helps biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene/cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment develops and produces industrial enzymes through non-pathogenic microbial strains constructed using genetic engineering. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the People’s Republic of China.

Compare 1548 to Peers and Sector

Metrics to compare
1548
Peers
Sector
Relationship
P/E Ratio
−70.0x−2.7x−0.5x
PEG Ratio
−0.020.090.00
Price/Book
1.1x2.4x2.6x
Price / LTM Sales
7.9x4.0x3.3x
Upside (Analyst Target)
29.2%77.6%43.4%
Fair Value Upside
Unlock19.7%7.1%Unlock

Analyst Ratings

10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 21.61
(+27.48% Upside)

Earnings

Latest Release
Aug 29, 2024
EPS / Forecast
-0.08 / 0.23
Revenue / Forecast
561.37M / --
EPS Revisions
Last 90 days

1548 Income Statement

People Also Watch

88.62
QRVO
+1.22%
29.36
2269
-2.20%
17.42
9969
-1.25%
111.20
1211
-1.42%
61.41
TEM
+4.55%

FAQ

What Stock Exchange Does Genscript Biotech Corp Trade On?

Genscript Biotech Corp is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Genscript Biotech Corp?

The stock symbol for Genscript Biotech Corp is "1548."

What Is the Genscript Biotech Corp Market Cap?

As of today, Genscript Biotech Corp market cap is 37.01B.

What Is Genscript Biotech Corp's Earnings Per Share (TTM)?

The Genscript Biotech Corp EPS (TTM) is -0.03.

From a Technical Analysis Perspective, Is 1548 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Genscript Biotech Corp Stock Split?

Genscript Biotech Corp has split 0 times.

How Many Employees Does Genscript Biotech Corp Have?

Genscript Biotech Corp has 5568 employees.

What is the current trading status of Genscript Biotech Corp (1548)?

As of 08 Aug 2025, Genscript Biotech Corp (1548) is trading at a price of 16.95, with a previous close of 17.21. The stock has fluctuated within a day range of 16.76 to 17.29, while its 52-week range spans from 8.88 to 18.96.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.